• Canadian Critical Care Trials Group
    The Canadian Critical Care Trials Group (CCCTG) is a highly collegial group that is dedicated to the pursuit of excellence and advancement of critical care research in Canada.
  • Canadian Critical Care Trials Group
    The CCCTG has are more than 30 research programs underway and over 100 peer-reviewed publications to its credit, with direct impact on clinical practice in critical care.
  • Canadian Critical Care Trials Group
    The Canadian Critical Care Trials Group (CCCTG) is a national organization of more than 300 individuals with research interests in the management of the critically ill patient.
  • Canadian Critical Care Trials Group
    Endorsement by the CCCTG communicates our full commitment to ensure that the work is undertaken in a rigorous and ethical manner, and communicated in a timely and effective way.
Coordinates

Institution

Centre hospitalier de l'Université de Sherbrooke

City

Sherbrooke

Contact This Member

François Lamontagne

François Lamontagne joined the Canadian Critical Care Trials Groups in 2006 as a trainee and now holds a master’s degree in pharmacology (Université de Sherbrooke), another in Clinical Epidemiology and Biostatistics (McMaster University), a certificate from the Royal College of Physicians and Surgeons of Canada’s Clinician Investigator Program (McMaster University), a Canadian Institutes for Health Research Randomized Controlled Trial Mentoring Award and a Fonds de Recherche du Québec en Santé junior-1 career award.

François Lamontagne holds a position as assistant professor at the Université de Sherbrooke and practices as an intensivist at the Centre Hospitalier Universitaire de Sherbrooke as well as a researcher in the Centre de recherche clinique Étienne-Le Bel. He is the instigator of the Research Platform for Patient-Centered Research at these institutions, a resource designed to facilitate investigator-led, peer-review funded research projects chiefly conducted on behalf of the Canadian Critical Care Trials Group. He joined the Canadian Critical Care Trials Groups in 2006 as a trainee and now holds a master’s degree in pharmacology (Université de Sherbrooke), another in Clinical Epidemiology and Biostatistics (McMaster University), a certificate from the Royal College of Physicians and Surgeons of Canada’s Clinician Investigator Program (McMaster University), a Canadian Institutes for Health Research Randomized Controlled Trial Mentoring Award and a Fonds de Recherche du Québec en Santé junior-1 career award. Having received mentorship from accomplished researchers within the Canadian Critical Care Trials group, he now leads the Optimal VAsopressor TItratiON (OVATION) research program under its auspices.